6,364 Shares in Cigna Group $CI Bought by Center for Wealth Management Advisory

Center for Wealth Management Advisory bought a new position in shares of Cigna Group (NYSE:CIFree Report) during the 1st quarter, HoldingsChannel reports. The institutional investor bought 6,364 shares of the health services provider’s stock, valued at approximately $1,698,000. Cigna Group comprises approximately 1.2% of Center for Wealth Management Advisory’s investment portfolio, making the stock its 27th largest position.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Root Financial Partners LLC raised its position in shares of Cigna Group by 42.6% during the first quarter. Root Financial Partners LLC now owns 669 shares of the health services provider’s stock worth $178,000 after purchasing an additional 200 shares during the period. Capital Asset Advisory Services LLC grew its position in shares of Cigna Group by 144.1% in the 1st quarter. Capital Asset Advisory Services LLC now owns 2,719 shares of the health services provider’s stock valued at $761,000 after purchasing an additional 1,605 shares during the period. Essex Financial Services Inc. grew its position in shares of Cigna Group by 1.9% in the 1st quarter. Essex Financial Services Inc. now owns 9,775 shares of the health services provider’s stock valued at $2,607,000 after purchasing an additional 183 shares during the period. CHICAGO TRUST Co NA increased its stake in Cigna Group by 281.9% during the 1st quarter. CHICAGO TRUST Co NA now owns 4,014 shares of the health services provider’s stock worth $1,071,000 after purchasing an additional 2,963 shares in the last quarter. Finally, USS Investment Management Ltd increased its stake in Cigna Group by 1.9% during the 1st quarter. USS Investment Management Ltd now owns 42,886 shares of the health services provider’s stock worth $11,439,000 after purchasing an additional 781 shares in the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Cigna Group Stock Performance

Shares of NYSE CI opened at $276.67 on Thursday. Cigna Group has a 12 month low of $239.51 and a 12 month high of $332.29. The company has a market capitalization of $73.19 billion, a P/E ratio of 11.73, a P/E/G ratio of 1.06 and a beta of 0.29. The stock has a 50 day moving average of $284.61 and a 200-day moving average of $279.09. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CIGet Free Report) last posted its earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. The company had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The firm’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.74 earnings per share. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, equities research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th were issued a $1.56 dividend. The ex-dividend date of this dividend was Thursday, June 4th. This represents a $6.24 annualized dividend and a yield of 2.3%. Cigna Group’s payout ratio is currently 26.45%.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CAO Jamie G. Kates sold 899 shares of the company’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on the stock. Piper Sandler cut their price target on shares of Cigna Group from $370.00 to $346.00 and set an “overweight” rating on the stock in a research note on Wednesday, June 3rd. Raymond James Financial set a $340.00 price objective on shares of Cigna Group in a research report on Friday, May 1st. Sanford C. Bernstein raised their price objective on shares of Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a report on Tuesday, May 5th. Mizuho boosted their price objective on shares of Cigna Group from $330.00 to $340.00 and gave the company an “outperform” rating in a research report on Monday, June 8th. Finally, Barclays lowered shares of Cigna Group from an “overweight” rating to an “equal weight” rating and reduced their target price for the stock from $310.00 to $304.00 in a research note on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $338.30.

Get Our Latest Research Report on CI

Cigna Group Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Featured Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.